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Molecular karyotyping by pulsed field gel electrophoresis was used to characterize Trypanosoma 
evansi isolates. Ten T. evansi isolates from camels were collected in Eastern and Western Sudan. 
Isolates from Eastern Sudan which were kept under continuous prophylactic treatment with 
quinapyramine (Trypacide®), were found to bear a single pattern and belonged to one karyotype group. 
From Western Sudan where trypanosomosis management was done by individual treatment of proven 
parasitaemic cases, isolates with diverse karyotype patterns were obtained. This study concluded that 
the occurrence of karyotype homogeneity amongst T. evansi isolates from field situations where anti-
trypanosomal compounds have been used may infer the existence of drug-resistance. 
 





Trypanosomosis caused by Trypanosoma evansi (Surra) 
has been recorded in Africa, South America and the 
Middle East (Luckins et al., 1979). In Sudan, this parasite 
has been reported in different regions since 1908, 
affecting camels and to lesser extent horses. The 
extensive use of commercially available trypanocides 
such as suramin and quinapyramine (Trypacide®) has 
resulted in the appearance of strains resistant to these 
drugs (Boid et al., 1989). Such drug-resistance has been 
an important subject in the study of these parasites 
(Zhang et al., 1992, 1993; El Rayah et al., 1999; Luckins, 
2000). Waitumbi and Young (1994) observed that 
distinguishing T. evansi isolates by molecular 
electrophoretic karyotype is more discriminating than 
kDNA analysis. Hence, the observation of karyotype 
patterns reocurring in isolates from herds kept under 
chemoprophylaxis could help in the identification of drug-
resistant parasites. 
The aim of this study was  to  characterize  the  isolates  
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by molecular karyotyping to see whether there are any 
differences between sensitive and resistant isolates. 
 
 




Tweleve  T. evansi isolates from Eastern and Western Sudan and 
one from Kenya were used. Their origins, designation, date of 
isolation, and drug sensitivities were previously described (El Rayah 
et al., 1999) and are summarized in Table 1. 
 
 
Preparation of trypanosome suspensions 
 
Female Swiss ICR mice were infected by intraperitoneal inoculation 
of thawn cryopreserved stabilates of T. evansi. After 2-4 days, when 
the mice showed rising parasitaemia, they were bled by cardiac 
puncture while under anesthesia, using a heparinized syringe. The 
trypanosomes were separated from the blood by anion-exchange 
chromatography on DE53 cellulose (Whatman Biosystems Ltd. UK.) 
as previously described by Lanham and Godfrey (1970). 
Trypanosomes were counted in CASY1 (Schaerfe system; 
Reutlingen, FRG) cell-analyzing systems. Cleaned trypanosomes 
suspension were centrifuged for 15 min at 2500 rpm at 6oC; then 
the pellet was resuspended in 10 ml PSG (phosphate  buffer  saline  






















                                                 






Figure 1. Large sized chromosomes of sudanese T. evansi. 
Location: [E]: Isolates from Eastern Sudan, [W]: Isolates from Western Sudan, [K]: Isolate originally from Kenya. 
Type: A, B, C to F (Karyotype patterns). 
Tracks: [1] Eastry 1, [2] Eastry2, [3] Eastry 3, [4] Eastry 4, [5] Eastry 5, [6] Eastry 6, [7] Westry1, [8] Westry 2, [9] 
Westry 5, [10] Westry 4, [11] Westry 3, [12] Westry 6, [13] STIB 779 clone 1,  [M] S. cerevisiae. 
 
 
Quinapyramine Isolate Origin Year 
MCD100 
Eastry  1a Kassla 1994 >10 
Eastry  2 Kassla 1994 >10 
Eastry  3 Toker 1994 4 
Eastry  4 Kassala 1994 >10 
Eastry  5 Elhabsha 1994 >10 
Eastry  6 Elgadriff 1995 >10 
Westry 1b Elobied 1993 4 
Westry 2 Ryash 1995 3 
Westry 3 BurBur 1996 >10 
Westry 4 Elkhorelbyied 1996 >10 
Westry 5 BurBur 1996 315(IC50) 
Westry 7 Elobied 1996 103(IC50) 
Stib 779(1)c Kenya 1979 >8 






Figure 2. Intermediate- sized chromosomes of Sudanese T. evans. 
Location: [E]: Isolates from Eastern Sudan, [W]: Isolates from Western Sudan, [K]: Isolate originally from Kenya. 
Type: A, B, C to F (Karyotype patterns). 
Tracks: [1] Eastry 1, [2] Eastry2, [3] Eastry 3, [4] Eastry 4, [5] Eastry 5, [6] Eastry 6, [7] Westry1, [8] Westry 2, [9] 




glucose) and further centrifuged at the same speed. Finally the 
pellet was resuspended in 750 µl PSG, transferred into eppendorf 
tube, and centrifuged for 10 min at 1000 g . The supernatent was 
discarded and the pellet stored in ice. 
 
 
Pulsed field gel electrophoresis 
 
Chromsomal DNA was prepared in agarose blocks as previously 
described (Van der Pleog et al., 1984a, 1984b). Pulsed field gel 
electrophorsesis (PFG) was carried out using a Pulsaphore 
apparatus (Pharmacia LKB) with hexagonal electrode array. 
Agarose gel (1%) was applied. For large chromosomes (1-3 MB) 6-
phase programme of 6 days [1200 s, 1000 s, 900 s, 800 s, 700 s, 
and 600 s (pulse frequency/second; 86 V)] was used.  For 
intermediate size (825-200 kb) 4-phase programme of 72 h ( 300 s, 
200 s, 150 s, 100 s; 110 V) was used. Gels were stained using 
ethidium bromide, 2 µg/ml and photographed. 
RESULTS 
 
Patterns of large and intermediate chromosomes DNA of 
T.evansi stocks are shown in Figures 1 and 2. The 
patterns were allocated A, B, C to F arbitrarily. The 
Sudanese T.evansi patterns were characterized by large 
numbers of large-sized chromosomes (3000-750 kb) and 
several discrete intermediate-sized chromosomes (825-
200 kb) which tended to be larger than those of 
Sacharomyces cerevisiae chromosome size-marker. All 
T. evansi stocks (Eastry 1-6) isolated from Eastern 
Sudan in 1994 showed the same pattern for large and 
intermediate-sized chromosomes (Figure 1, 2, tracks 1-5, 
pattern A). Eastry 6 which was isolated in 1995 showed a 
minor difference. It had an extra band of large-sized 
chromosomes (> 2200 kb) (Figure 1, track 6, pattern B). 




The Western isolates (Westry 1, 2, 3, 4, 5 and 7)  had 
individual karyotypes (Figure 2, tracks, 7, 8, 9, 10, 11, 12, 
13, patterns C, D, E, F) .Two isolates from Western 
Sudan (Westry  5 and 7) showed the same pattern 
(Figure 1, 2 , track 9, 10, pattern D), they were closely 
related to Eastry 6 (Track 12, pattern E), and they had 
more extra bands of intermediate-sized chromosomes.  
Westry 2 which was isolated in Western Sudan in 1995 
showed the same pattern of all Eastern isolates (Figure 1 
and 2, track 8, pattern A). T. evansi STIB 779 clone 1 
originally  isolated  from  Somalia  and  cloned  at   Swiss 
Tropical Institute, was used in this study for comparison 
with the sudanese isolates. It showed a different pattern 






Five of the Eastern Sudanese T. evansi isolates (Eastry 1 
– 5) were indistinguishable by PFG and another isolate 
(Eastry 6) shared 7 of 8 resolved bands comprising this 
karyotype. These isolates are therefore closely related, 
even though they were of different geographical origins in 
Eastern Sudan. It is worth mentioning that nomads in 
Eastern Sudan have good financial status that enables 
them to keep their animals under continuous 
chemoprophylactic treatment. However, this probably 
lead to the appearance of highly resistant T. evansi 
isolates to Quinayramine (Trypacide® ) by selection 
pressure, which may be expressed by the presence of a 
single karyotype pattern. The findings confirm the results 
of Waitumbi et al. (1994) who found that rigorous 
application of trypanocide may lead to homogeneity of 
karyotype patterns in camel herds, since karyotype 
heterogeneity has been observed in herds where 
trypanocide usage is less intense. In contrast, T. evansi 
isolates from Western Sudan showed different molecular 
karyotypes compared to Eastern T. evansi isolates. This 
may indicate that T. evansi was introduced more than 
once into Sudan and also it may be due to different drug 
regimes used in the Western Sudan. Lun et al. (1992) 
found indistinguishable karyotypes in remote isolates of 
T. evansi from China. It is unlikely that our T. evansi 
isolates and African T. evansi (Waitumbi and Young, 
1994) diverged faster than the same parasites in China. 
One isolate of T. evansi in Western Sudan has a 
karyotype pattern (pattern A) which was previously 
observed in the Eastern isolates. It  is  therefore  possible 
that the parasites with the karyotype pattern "A" infected 
camels in Eastern Sudan was introduced into Western 
Sudan. Different times of the isolation, regions and camel 
herd movements may explain the divergence in the 
karyotype patterns in this study. 
This study explains partially the persistence of drug-
resistance phenomenon in the field by application of a 
single trypanocidal drug for prolonged periods that may 
lead to selection pressure to the parasites which survive 





observations have important epidemiological implications 
in the control of T. evansi infections in camels. First, the 
data indicate that rigorous application of trypanocides 
may lead to a homogeneity of karyotype patterns in 
camel herds, since karyotype heterogeneity has been 
observed in herds where trypanocidal usage is less 
intense. Thus, the occurrence of karyotype homogeneity 
amongst T. evansi isolates from field situations where 
anti-trypanosomal compounds have been used may infer 
the existence of drug-resistant trypanosomes (Elrayah et 
al., 1999; Luckins, 2000). Secondly, because T. evansi 
karyotype appears to remain stable over long periods of 
time in vivo, molecular karyotyping is a useful 
epidemiological tool since it allows the dynamics of 
different trypanosomes populations to be studied in field 
situations. Neverthless, more studies is needed to 
investigate such a phenotype as observed in other 
different trypanosomes (e.g. T. b. brucie), in which some 
authors speculated that resistance is the result of loss of 
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